Digital Agency for Pharma Marketing & Healthcare

The EU Medical Device Regulation has drastically increased the requirements for approval, documentation, and post-market surveillance. The German Law on the Advertising of Medicines severely restricts digital communication. Every digital touchpoint — from the website to the patient portal — must be designed in compliance with the law.

Only 45% of HCP interactions reach physicians through their preferred channel. A well-thought-out HCP marketing strategy — one that seamlessly integrates in-person visits, webinars, professional portals, and email — is the new standard. Pharmaceutical sales representatives are losing access to healthcare professionals, who are increasingly conducting their own online research.

Patient portals, DiGA integration, and CRM systems process highly sensitive health data. 98% of all pharmaceutical companies have already been affected by cybersecurity incidents. Consent management and GDPR-compliant data processes are mandatory, not optional.

Creating content that complies with regulatory requirements for medical portals and specialized information is time-consuming and prone to errors. AI tools for automated claim verification, reference linking, and audit trail generation are fundamentally transforming content production.

The lack of integrated pharmaceutical CRM software leads to inconsistent communication with healthcare professionals (HCPs), duplicate data, and a lack of a 360-degree view of physicians and patients. Collaboration between Medical Affairs, brand teams, and the digital department remains fraught with friction.

With the DiGA fast-track procedure, Germany is a pioneer in the digital health market. Interoperability (HL7 FHIR), ecosystem partnerships, and digital value-added services beyond the core product are becoming a decisive competitive advantage.